Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects

NCT01873339 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: Darapladib
DRUG: Midazolam

Sponsor

GlaxoSmithKline